RRC ID 62860
著者 Li K, Sun S, Kageyama M, Xiao L, Xing G, Gao R, You F, Fu X, Zhang Z.
タイトル Evaluation of the Immunomodulatory and Anti-Inflammatory Activities of Honey Bee Larva Powder.
ジャーナル J Med Food
Abstract Honey bee larva powder (HLP) has traditionally been used as a daily supplement and tonic for health promotion with an uncertain scientific basis. In this study, B16-F10 tumor-bearing mice were established to evaluate the immunomodulatory activity of HLP. The proliferation and apoptosis assays were performed to evaluate the anti-inflammatory activity of honey bee larva extract (HLE) in RAW 264.7 macrophage. The in vivo experimental results demonstrated that the oral administration of freeze-dried HLP (4 and 6 g/kg) significantly enhanced the spleen index, the percentage of CD4+cells, and the ratio of CD4+ and CD8+ T lymphocytes (CD4+/CD8+) in the peripheral blood compared with those in the tumor control mice. The in vitro studies demonstrated the potent immunomodulatory activities of HLE through the induction of RAW 264.7 macrophage proliferation and the mitigation of doxorubicin (DOX)-induced toxicity. HLE also exhibits anti-inflammatory activity by decreasing the production of nitric oxide (NO) and the cytokine level of interleukin-6 (IL-6) in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophage. The present study provides important scientific evidence for the immunomodulatory and anti-inflammatory activities of HLP and HLE.
巻・号 23(7)
ページ 772-782
公開日 2020-7-1
DOI 10.1089/jmf.2019.4554
PMID 32456573
MeSH Administration, Oral Animals Anti-Inflammatory Agents* / pharmacology Bees* Biological Products / pharmacology* Doxorubicin / toxicity Immunomodulation* Interleukin-6 / metabolism Larva Lipopolysaccharides Melanoma, Experimental Mice Nitric Oxide / metabolism Powders RAW 264.7 Cells
IF 2.04
リソース情報
ヒト・動物細胞 B16F10(RCB2630)